Reported Earlier, Spruce Biosciences Prices Public Offering Of 1.15M Shares And Pre-Funded Warrants At $50.00 Per Share, Raising $60M Gross Proceeds

Benzinga Newsdesk www.benzinga.com Positive 74.2%